FDA OKs Pancreatic Islet Cell Therapy for Type 1 Diabetes

Approval of Lantidra, a beta cell therapy derived from donor pancreatic islets, came despite transplant surgeons' concerns about FDA regulating these cells as biologics rather than transplanted organs.
Medscape Medical News

source https://www.medscape.com/viewarticle/993854?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?